Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis.
Jeayeon ParkYun Bin LeeYunmi KoYoungsu ParkHyunjae ShinMoon Haeng HurMin Kyung ParkDae-Won LeeEun Ju ChoKyung-Hun LeeJeong-Hoon LeeSu Jong YuTae-Yong KimYoon Jun KimTae-You KimJung-Hwan YoonPublished in: Journal of liver cancer (2024)
The effectiveness of atezolizumab plus bevacizumab and lenvatinib was comparable for the treatment of HCC with PVTT.